Nitrosamines – Risk evaluation outcome: risk of nitrosamine presence identified

Questions and answers on how to correctly fill in this webform

* Mandatory field

Surname and first name

E-mail

Marketing Authorisation Holder name

Marketing Authorisation Holder address

Name of medicine

Type of product

Type of API

Active pharmaceutical ingredient (API)/intermediate

Marketing Authorisation Number

Procedure Number (DCP, MRP, NAT)

For DCP and MRP use the country code + product counter of maximum 4 numbers, for example BE-106. For national procedure use NAT + product counter of maximum 4 numbers, for example NAT-1125

API manufacturer name

API manufacturer address

Finished product manufacturer name

Finished product manufacturer address

Start of testing

Completion of testing

Date of submission of update

Upload signed version of the form

One file only.
25 MB limit.
Allowed types: jpg, jpeg, png, txt, pdf, doc, docx, ppt, pptx, xls, xlsx, rar, zip.

Upload Excel spreadsheet

One file only.
25 MB limit.
Allowed types: pdf, xls, xlsx, rar, zip.

Nitrosamines – Risk evaluation outcome: risk of nitrosamine presence identified

* Mandatory field

Privacy